Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: A systematic review

被引:31
作者
Ghazali, Naseem [1 ,2 ]
Shaw, Richard J. [1 ,2 ]
Rogers, Simon N. [1 ,3 ]
Risk, Janet M. [2 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Reg Maxillofacial Unit, Liverpool L9 7AL, Merseyside, England
[2] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Studies, Liverpool L69 3GA, Merseyside, England
[3] Edge Hill Univ, Fac Hlth, Evidence Based Res Practice Ctr, Omskirk, Lancs, England
关键词
Head and neck cancer; Radiotoxicity; Radiotherapy; Toxicity; Genetic polymorphism; Genetic association study; Single nucleotide polymorphism; SINGLE NUCLEOTIDE POLYMORPHISMS; QUALITY-OF-LIFE; DNA-REPAIR GENES; RADIATION-THERAPY; CANCER-PATIENTS; MOLECULAR MARKERS; INTERMEDIATE RISK; PROSTATE-CANCER; ASSOCIATION; RADIOSENSITIVITY;
D O I
10.1016/j.oraloncology.2012.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interindividual variations in radiotoxicity responses exist despite uniform treatment protocols. It is speculated that normal genetic variants, particularly single nucleotide polymorphisms (SNPs) may influence normal head and neck (HN) tissue radiotoxicity. This first-ever systematic review was undertaken to evaluate the association of SNPs with normal HN tissues radiotoxicity. Multiple databases (1950-February 2012) were reviewed using a combination of related keywords and MeSH terms. All published HN radiotoxicity studies with sufficient relevant data for extraction were included. The outcomes evaluated were acute and late radiotoxicity endpoints. Methodological quality assessment based on the STrengthening the REporting of Genetic Association (STREGA) statement was performed. Seven articles from 692 articles searched fulfilled the eligibility criteria. Recruited sample sizes were small (range, 32-140). There were 5/7 case-control studies. All studies used multimodality treatment with heterogeneous radiation parameters. Candidate gene approach was used in all studies. Fourteen SNPs from 9 genes were evaluated from the following pathways: DNA damage response, radiation fibrogenesis and oxidative/xenobiotic metabolism. Acute radiotoxicity events were associated with SNPs of DNA repair genes (OR, 3.01-4.08). SNPs of TGF beta 1 were associated with osteoradionecrosis (OR, 4.2) and subcutaneous fibrosis. Genetic association studies in HN radiotoxicity currently provide hypothesis-generating findings that require validation in larger studies. Future studies must incorporate critical methodological issues and technological improvements, including using a genome-wide approach. Headway is possible through case-pooling of existing clinical trial data which could create a larger sample size of well-characterized treatment and endpoints. Also, on-going HN cancer clinical trials should consider extending their toxicity evaluation to include genetic association studies. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1090 / 1100
页数:11
相关论文
共 50 条
  • [41] A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer
    Langendijk, Johannes A.
    Doornaert, Patricia
    Rietveld, Derek H. F.
    Verdonck-de Leeuw, Irma M.
    Leemans, C. Rene
    Slotman, Ben J.
    RADIOTHERAPY AND ONCOLOGY, 2009, 90 (02) : 189 - 195
  • [42] Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review
    Garg, Shashank
    Yoo, John
    Winquist, Eric
    SUPPORTIVE CARE IN CANCER, 2010, 18 (06) : 667 - 677
  • [43] Salivary molecules of bone remodeling and tissue repair after head and neck radiotherapy
    de Oliveira, Eduardo Morato
    Guieiro, Rafael Soares
    Cruz, Barbara Lima
    Ferreira de Aguiar, Maria Cassia
    da Silva, Janine Mayra
    Silva, Tarcilia Aparecida
    Caldeira, Patricia Carlos
    BRAZILIAN ORAL RESEARCH, 2021, 35 : 1 - 8
  • [44] Improved Normal Tissue Sparing in Head and Neck Radiotherapy Using Biological Cost Function Based-IMRT
    Anderson, N.
    Lawford, C.
    Khoo, V.
    Rolfo, M.
    Joon, D. Lim
    Wada, M.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2011, 10 (06) : 575 - 583
  • [45] Risk of CVD Following Radiotherapy for Head and Neck Cancer: An Updated Systematic Review and Meta-Analysis
    Lin, Ping-Yi
    Cheng, Ping-Chia
    Hsu, Wan-Lun
    Lo, Wu-Chia
    Hsieh, Chen-Hsi
    Shueng, Pei-Wei
    Liao, Li-Jen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] A systematic review of interventions to mitigate radiotherapy-induced oral mucositis in head and neck cancer patients
    Catrina Davy
    Sharron Heathcote
    Supportive Care in Cancer, 2021, 29 : 2187 - 2202
  • [47] Prevalence of carotid stenosis following radiotherapy for head and neck cancer: A systematic review and meta-analysis
    Texakalidis, Pavlos
    Giannopoulos, Stefanos
    Tsouknidas, Ioannis
    Song, Shiyu
    Rivet, Dennis J.
    Reiter, Evan R.
    Reavey-Cantwell, John
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (05): : 1077 - 1088
  • [48] Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio
    Rooney, Michael K.
    Andring, Lauren M.
    Corrigan, Kelsey L.
    Bernard, Vincent
    Williamson, Tyler D.
    Fuller, Clifton D.
    Garden, Adam S.
    Gunn, Brandon
    Lee, Anna
    Moreno, Amy C.
    Morrison, William H.
    Phan, Jack
    Rosenthal, David I.
    Spiotto, Michael
    Frank, Steven J.
    De Felice, Francesca
    CANCERS, 2023, 15 (17)
  • [49] Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review
    Schanne, Daniel H.
    Koch, Alexander
    Elicin, Olgun
    Giger, Roland
    Medova, Michaela
    Zimmer, Yitzhak
    Aebersold, Daniel M.
    BIOMEDICINES, 2022, 10 (12)
  • [50] A systematic review of interventions to mitigate radiotherapy-induced oral mucositis in head and neck cancer patients
    Davy, Catrina
    Heathcote, Sharron
    SUPPORTIVE CARE IN CANCER, 2021, 29 (04) : 2187 - 2202